# Healing of induced tongue defects using erythropoietin hydrogel (an experimental study on rats)

**Authors:** Fatma Ata, Rana El-Qashty, Meran Farid, Jilan Youssef

PMC · DOI: 10.1186/s12903-024-04161-5 · 2024-03-27

## TL;DR

This study shows that erythropoietin hydrogel can speed up healing of tongue defects in rats by reducing inflammation and promoting blood vessel growth.

## Contribution

The novel use of erythropoietin hydrogel to accelerate tongue tissue regeneration and reduce inflammation is demonstrated experimentally.

## Key findings

- EPO-treated rats showed significantly enhanced tissue regeneration and reduced defect depth.
- EPO reduced iNOS levels and increased VEGF, indicating anti-inflammatory and neovascularization effects.
- Histological analysis confirmed better blood vessel development in EPO-treated groups.

## Abstract

Tongue is complex muscular organ that may be affected by recurrent or chronic ulcerations and malignances that require effective treatment to enhance healing and tissue regeneration. So, this study aimed to evaluate the efficiency of erythropoietin (EPO) hydrogel as an anti-inflammatory and an inducer of neovascularization during healing of induced rats’ tongue defects.

Thirty six rats were divided into three groups; Group I (negative control): tongues were left without ulceration and received no treatment, Group II (positive control): tongue defects were prepared on the tongues’ dorsal surfaces, measuring (5 mm × 2 mm) using a tissue punch rotary drill for standardization, and left untreated, Group III (EPO group): tongue defects were prepared as in group II, then injected circumferentially around wound margins with a single high dose of EPO hydrogel of 5000 U/kg on the day of defect preparation. Animals were euthanized on seventh and fourteenth days after treatment, tongue specimens were collected, and paraffin blocks were prepared and processed for histological assessment by hematoxylin and eosin stain and immunohistochemical evaluation of anti-iNOS and anti-VEGF followed by histomorphometrical analysis and the relevant statistical tests.

At both time points, the EPO treated group showed significantly enhanced tissue regeneration marked by the histologically better regenerated tissue with well developed, thick walled and well-organized blood vessels and significant reduction in defect depth compared to positive control group. EPO group also showed significant decrease in iNOS and significant increase in VEGF antibodies indicating its anti-inflammatory and neovascularization effects respectively.

EPO treatment can significantly accelerate regeneration and filling of tongue defects by reducing tissue inflammation and enhancing neovascularization. Therefore, EPO could be a potential therapeutic strategy for accelerating healing of tongue ulcers. However, further investigations are required to optimize the dose and unravel any potential side effects before its clinical application.

## Linked entities

- **Proteins:** NOS2 (nitric oxide synthase 2), VEGFA (vascular endothelial growth factor A)
- **Chemicals:** erythropoietin (PubChem CID 92043599)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, ISYNA1 (inositol-3-phosphate synthase 1) [NCBI Gene 51477] {aka INO1, INOS, IPS, IPS 1, IPS-1}, EPO (erythropoietin) [NCBI Gene 2056] {aka DBAL, ECYT5, EP, MVCD2}
- **Diseases:** inflammation (MESH:D007249), tongue defects (MESH:D014060)
- **Chemicals:** hematoxylin (MESH:D006416), eosin (MESH:D004801), paraffin (MESH:D010232)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10967061/full.md

---
Source: https://tomesphere.com/paper/PMC10967061